Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement
May 11, 2017 20:52 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, May 11, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced the following.In accordance with Rule 2.10 of the Irish Takeover Panel Act 1997, Takeover Rules, 2013...
Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2017
May 11, 2017 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, May 11, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and nine month periods ended March 31, 2017. Recent highlights: ...
Nexvet to Present at the Cowen and Company 37th Annual Health Care Conference
February 22, 2017 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced that its Chief Executive Officer, Dr. Mark Heffernan, is scheduled to present at the Cowen and...
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017
February 10, 2017 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Feb. 10, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and six month periods ended December 31, 2016.Recent...
Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in Cats
December 12, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced it has initiated a pivotal field efficacy and safety study of frunevetmab, the Company’s anti-nerve...
Nexvet Reports Financial Results for First Quarter of Fiscal Year 2017
November 04, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Nov. 04, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three month period ended September 30, 2016. Recent highlights...
Nexvet to Present at the 25th Annual Credit Suisse Healthcare Conference
October 19, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, today announced that its Chief Executive Officer, Dr. Mark Heffernan, is...
Nexvet Biopharma Reports Full Year Fiscal 2016 Results
September 02, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, Sept. 02, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, today announced financial results for its 2016 fiscal year, which...
Nexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02) and Presentation at the Veterinary Pain Short Course Conference
July 20, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, July 20, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, today announced the recent publication of two peer-reviewed papers...
Nexvet Presents Expanded Positive Clinical Data for Ranevetmab (NV-01) and Frunevetmab (NV-02) at ACVIM
June 09, 2016 05:30 ET
|
Nexvet Biopharma plc
DUBLIN, Ireland, June 09, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, is today presenting expanded results regarding completed clinical...